Closely held Biomet Inc. reported modestly higher sales of hip and knee replacements for its most recent quarter, providing hope to investors that the orthopedic market may be improving.
Biomet’s results are closely watched because the company reports earlier than larger competitors—such as Zimmer Holdings Inc., Stryker Corp. and Johnson & Johnson—and could foreshadow industry trends. The company, which distributes products in about 90 countries, said hip sales increased 6% world-wide, excluding …
